{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T02:56:53Z","timestamp":1784516213389,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T00:00:00Z","timestamp":1611273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T00:00:00Z","timestamp":1611273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1038\/s41371-020-00451-x","type":"journal-article","created":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T18:11:02Z","timestamp":1611339062000},"page":"304-307","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["COVID-19 and hypertension: risks and management. A scientific statement on behalf of the British and Irish Hypertension Society"],"prefix":"10.1038","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7526-3038","authenticated-orcid":false,"given":"Christopher E.","family":"Clark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinead T. J.","family":"McDonagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3638-028X","authenticated-orcid":false,"given":"Richard J.","family":"McManus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9749-5502","authenticated-orcid":false,"given":"Una","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,22]]},"reference":[{"key":"451_CR1","unstructured":"Global Burden of Disease 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1659\u2013724."},{"key":"451_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0140-6736(05)17741-1","volume":"365","author":"PM Kearney","year":"2005","unstructured":"Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217\u201323.","journal-title":"Lancet"},{"key":"451_CR3","unstructured":"Who\u2019s at higher risk from coronavirus. https:\/\/www.nhs.uk\/conditions\/coronavirus-covid-19\/people-at-higher-risk\/whos-at-higher-risk-from-coronavirus\/ NHS England 7\/1\/21; accessed 18 Jan 2021."},{"key":"451_CR4","unstructured":"Health Service Executive. At-risk groups: coronavirus (COVID-19). https:\/\/www2.hse.ie\/conditions\/coronavirus\/at-risk-groups.html; 5\/4\/20; accessed 6 Apr 2020."},{"key":"451_CR5","unstructured":"British Heart Foundation. Coronavirus: what it means for you if you have heart or circulatory disease. https:\/\/www.bhf.org.uk\/informationsupport\/heart-matters-magazine\/news\/coronavirus-and-your-health 3\/4\/20; accessed 6 Apr 2020."},{"key":"451_CR6","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497\u2013506.","journal-title":"Lancet"},{"key":"451_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.46234\/ccdcw2020.032","volume":"2","author":"The Novel Coronavirus Pneumonia Emergency Response Epidemiology T","year":"2020","unstructured":"The Novel Coronavirus Pneumonia Emergency Response Epidemiology T. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) \u2014 China, 2020. China CDC Weekly. 2020;2:113\u201322.","journal-title":"China CDC Weekly"},{"key":"451_CR8","doi-asserted-by":"publisher","unstructured":"Williamson E, Walker AJ, Bhaskaran KJ, Bacon S, Bates C, Morton CE, et al. OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients. medRxiv. 2020. https:\/\/doi.org\/10.1101\/2020.05.06.20092999.","DOI":"10.1101\/2020.05.06.20092999"},{"key":"451_CR9","doi-asserted-by":"publisher","first-page":"m1091","DOI":"10.1136\/bmj.m1091","volume":"368","author":"T Chen","year":"2020","unstructured":"Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091.","journal-title":"BMJ"},{"key":"451_CR10","doi-asserted-by":"crossref","first-page":"304","DOI":"10.20452\/pamw.15448","volume":"130","author":"G Lippi","year":"2020","unstructured":"Lippi G, Wong J, Henry BM. Hypertension in patients with coronavirus disease 2019 (COVID-19): a pooled analysis. Pol Arch Intern Med. 2020;130:304\u20139.","journal-title":"Pol Arch Intern Med"},{"key":"451_CR11","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054\u201362.","journal-title":"Lancet"},{"key":"451_CR12","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ijid.2016.06.015","volume":"49","author":"A Badawi","year":"2016","unstructured":"Badawi A, Ryoo SG. Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis. Int J Infect Dis. 2016;49:129\u201333.","journal-title":"Int J Infect Dis"},{"key":"451_CR13","first-page":"323","volume":"66","author":"WW Wong","year":"2003","unstructured":"Wong WW, Chen TL, Yang SP, Wang FD, Cheng NC, Kuo BI, et al. Clinical characteristics of fatal patients with severe acute respiratory syndrome in a medical center in Taipei. J Chin Med Assoc. 2003;66:323\u20137.","journal-title":"J Chin Med Assoc"},{"key":"451_CR14","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1001\/jamacardio.2020.1017","volume":"5","author":"T Guo","year":"2020","unstructured":"Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5:811\u201318.","journal-title":"JAMA Cardiol"},{"key":"451_CR15","doi-asserted-by":"crossref","unstructured":"The SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373:2103\u201316.","DOI":"10.1056\/NEJMoa1511939"},{"key":"451_CR16","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","volume":"360","author":"S Lewington","year":"2002","unstructured":"Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903\u201313.","journal-title":"Lancet"},{"key":"451_CR17","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1001\/jama.2019.20153","volume":"323","author":"JM Sanders","year":"2020","unstructured":"Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;323:1824\u201336.","journal-title":"JAMA"},{"key":"451_CR18","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","volume":"8","author":"L Fang","year":"2020","unstructured":"Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020;8:e21.","journal-title":"Lancet Respir Med"},{"key":"451_CR19","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1080\/22221751.2020.1746200","volume":"9","author":"J Meng","year":"2020","unstructured":"Meng J, Xiao G, Zhang J, He X, Ou M, Bi J, et al. Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension. Emerg Microbes Infect. 2020;9:757\u201360.","journal-title":"Emerg Microbes Infect"},{"key":"451_CR20","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","volume":"382","author":"M Vaduganathan","year":"2020","unstructured":"Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD. Renin-angiotensin-aldosterone system inhibitors in patients with covid-19. N Engl J Med. 2020;382:1653\u20139.","journal-title":"N Engl J Med"},{"key":"451_CR21","doi-asserted-by":"publisher","first-page":"m1548","DOI":"10.1136\/bmj.m1548","volume":"369","author":"K Khunti","year":"2020","unstructured":"Khunti K, Singh AK, Pareek M, Hanif W. Is ethnicity linked to incidence or outcomes of covid-19? BMJ. 2020;369:m1548.","journal-title":"BMJ"},{"key":"451_CR22","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","volume":"395","author":"R Lu","year":"2020","unstructured":"Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395:565\u201374.","journal-title":"Lancet"},{"key":"451_CR23","unstructured":"National Institute for Health and Care Excellence. Coronavirus (COVID-19). 2020. https:\/\/www.nice.org.uk\/covid-19; accessed 6 Apr 2020."},{"key":"451_CR24","doi-asserted-by":"crossref","unstructured":"Mancia G, Rea F, Ludergnani M, Apolone G, Corrao G. Renin\u2013angiotensin\u2013aldosterone system blockers and the risk of covid-19. N Engl J Med. 2020;382:2431\u201340.","DOI":"10.1056\/NEJMoa2006923"},{"key":"451_CR25","doi-asserted-by":"crossref","unstructured":"Reynolds HR, Adhikari S, Pulgarin C, Troxel AB, Iturrate E, Johnson SB, et al. Renin\u2013angiotensin\u2013aldosterone system inhibitors and risk of covid-19. N Engl J Med. 2020;382:2441\u20138.","DOI":"10.1056\/NEJMoa2008975"},{"key":"451_CR26","doi-asserted-by":"crossref","unstructured":"Mehta N, Kalra A, Nowacki AS, Anjewierden S, Han Z, Bhat P. Association of use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with testing positive for coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5:1020\u20136.","DOI":"10.1001\/jamacardio.2020.1855"},{"key":"451_CR27","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1056\/NEJMe2012924","volume":"382","author":"JA Jarcho","year":"2020","unstructured":"Jarcho JA, Ingelfinger JR, Hamel MB, D\u2019Agostino RB, Harrington DP. Inhibitors of the renin\u2013angiotensin\u2013aldosterone system and covid-19. N Engl J Med. 2020;382:2462\u20134.","journal-title":"N Engl J Med"},{"key":"451_CR28","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.1874","author":"LE Thomas","year":"2020","unstructured":"Thomas LE, Bonow RO, Pencina MJ. Understanding observational treatment comparisons in the setting of coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020. https:\/\/doi.org\/10.1001\/jamacardio.2020.1874","journal-title":"JAMA Cardiol"},{"key":"451_CR29","unstructured":"British and Irish Hypertension Society. BIHS statement on ACEi\/ARB and COVID-19. 2020 https:\/\/bihsoc.org\/bihs-statement-on-acei-arb-and-covid19\/; accessed 6 Apr 2020."},{"key":"451_CR30","doi-asserted-by":"publisher","first-page":"m1313","DOI":"10.1136\/bmj.m1313","volume":"369","author":"JK Aronson","year":"2020","unstructured":"Aronson JK, Ferner RE. Drugs and the renin-angiotensin system in covid-19. BMJ. 2020;369:m1313.","journal-title":"BMJ"},{"key":"451_CR31","doi-asserted-by":"publisher","unstructured":"Kass DA, Duggal P, Cingolani O. Obesity could shift severe COVID-19 disease to younger ages. The Lancet 4\/5\/20. https:\/\/doi.org\/10.1016\/S0140-6736(20)31024-2 (accessed 12 May 2020.).","DOI":"10.1016\/S0140-6736(20)31024-2"},{"key":"451_CR32","doi-asserted-by":"crossref","unstructured":"Sattar N, McInnes IB, McMurray JJV. Obesity a risk factor for severe covid-19 infection: multiple potential mechanisms. Circulation. 2020 22\/4\/20; https:\/\/www.ahajournals.org\/doi\/abs\/10.1161\/CIRCULATIONAHA.120.047659 (accessed 12 May 2020.).","DOI":"10.1161\/CIRCULATIONAHA.120.047659"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41371-020-00451-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41371-020-00451-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41371-020-00451-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T21:21:30Z","timestamp":1724361690000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41371-020-00451-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,22]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["451"],"URL":"https:\/\/doi.org\/10.1038\/s41371-020-00451-x","relation":{},"ISSN":["0950-9240","1476-5527"],"issn-type":[{"value":"0950-9240","type":"print"},{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,22]]},"assertion":[{"value":"18 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}